Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -268385.71% is 3777% below its 5-year average of -6923.20%, around the middle of its 5-year range (-524566.67%–0.00%).
37.65% below its 12-month average of -194980.93%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -334104.55%.
NET PROFIT MARGIN
-268385.71%
NET PROFIT MARGIN AVG TTM
-194980.93%
NET PROFIT MARGIN AVG 3Y
-5823.90%
NET PROFIT MARGIN AVG 5Y
-6923.20%
NET PROFIT MARGIN AVG 10Y
-3105.65%
NET PROFIT MARGIN AVG 15Y
-2233.52%
NET PROFIT MARGIN AVG 20Y
-1523.08%
CURRENT VS TTM AVG
-37.65%
CURRENT VS 3Y AVG
-4508.35%
CURRENT VS 5Y AVG
-3776.61%
CURRENT VS 10Y AVG
-8541.85%
CURRENT VS 15Y AVG
-11916.26%
CURRENT VS 20Y AVG
-17521.20%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 574 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Celldex Therapeutics, Inc.
Market Cap
$2.09B
Net Profit Margin
-268385.71%
TTM Avg
-194980.93%
3Y Avg
-5823.90%
5Y Avg
-6923.20%
Market Cap
$2.10B
Net Profit Margin
7.13%
TTM Avg
6.55%
3Y Avg
5.96%
5Y Avg
5.57%
Market Cap
$2.11B
Net Profit Margin
-3.18%
TTM Avg
-24.20%
3Y Avg
-10.68%
5Y Avg
-8.90%
Market Cap
$2.05B
Net Profit Margin
-36.51%
TTM Avg
-21.30%
3Y Avg
-316.14%
5Y Avg
-299.31%
Market Cap
$2.01B
Net Profit Margin
-40.90%
TTM Avg
5.22%
3Y Avg
-37.29%
5Y Avg
-215.44%
Market Cap
$1.99B
Net Profit Margin
-13.36%
TTM Avg
-6.14%
3Y Avg
-11.71%
5Y Avg
-14.87%
Market Cap
$1.99B
Net Profit Margin
15.03%
TTM Avg
11.31%
3Y Avg
2.06%
5Y Avg
-9.89%
Market Cap
$1.99B
Net Profit Margin
100.84%
TTM Avg
51.96%
3Y Avg
-5.31%
5Y Avg
-103.82%
Market Cap
$1.99B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | $2.09B | -268385.71% | -194980.93% | -5823.90% | -6923.20% |
| Addus HomeCare Corporation (ADUS)vs › | $2.10B | 7.13% | 6.55% | 5.96% | 5.57% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.11B | -3.18% | -24.20% | -10.68% | -8.90% |
| Alvotech (ALVO)vs › | $2.05B | -36.51% | -21.30% | -316.14% | -299.31% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.01B | -40.90% | 5.22% | -37.29% | -215.44% |
| AxoGen, Inc. (AXGN)vs › | $1.99B | -13.36% | -6.14% | -11.71% | -14.87% |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.99B | 15.03% | 11.31% | 2.06% | -9.89% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $1.99B | 100.84% | 51.96% | -5.31% | -103.82% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.99B | 0.00% | 0.00% | 0.00% | 0.00% |
| Azenta, Inc. (AZTA)vs › | $1.95B | -20.02% | -19.08% | -29.38% | -13.21% |
Operating Margin
-19160.0%
Net Profit Margin
-268385.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -334104.55% |
| 2026-03-31 | -524566.67% |
| 2025-12-31 | -108480.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -7753.42% |
| 2025-03-31 | -7740.43% |
| 2024-12-31 | -4007.83% |
| 2024-09-30 | -1319.99% |
| 2024-06-30 | -1434.83% |
| 2024-03-31 | -21030.77% |
| 2023-12-31 | -1048.32% |
| 2023-09-30 | -2522.08% |
| 2023-06-30 | -11381.34% |
| 2023-03-31 | -3036.30% |
| 2022-12-31 | -1642.10% |
| 2022-09-30 | -6580.84% |
| 2022-06-30 | -22088.34% |
| 2022-03-31 | -13247.13% |
| 2021-12-31 | -6032.34% |
| 2021-09-30 | -13367.32% |
| 2021-06-30 | -384.28% |
| 2021-03-31 | -2414.31% |
| 2020-12-31 | -578.60% |
| 2020-09-30 | -2129.34% |
| 2020-06-30 | -4674.15% |
| 2020-03-31 | -462.79% |
| 2019-12-31 | -1177.79% |
| 2019-09-30 | -2090.29% |
| 2019-06-30 | -1647.41% |
| 2019-03-31 | -1209.75% |
| 2018-12-31 | -532.99% |
| 2018-09-30 | -769.71% |
| 2018-06-30 | -593.81% |
| 2018-03-31 | -2903.93% |
| 2017-12-31 | -111.14% |
| 2017-09-30 | -671.84% |
| 2017-06-30 | -746.04% |
| 2017-03-31 | -2233.44% |
| 2016-12-31 | -1723.96% |
| 2016-09-30 | -1333.24% |
| 2016-06-30 | -2300.36% |
| 2016-03-31 | -2661.01% |
| 2015-12-31 | -1825.92% |
| 2015-09-30 | -3116.96% |
| 2015-06-30 | -1485.72% |
| 2015-03-31 | -6208.64% |
| 2014-12-31 | -2154.43% |
| 2014-09-30 | -2550.59% |
| 2014-06-30 | -4776.01% |
| 2014-03-31 | -7188.22% |
| 2013-12-31 | -3558.39% |
| 2013-09-30 | -2361.22% |
| 2013-06-30 | -19604.12% |
| 2013-03-31 | -717.98% |
| 2012-12-31 | -460.84% |
| 2012-09-30 | -482.72% |
| 2012-06-30 | -685.56% |
| 2012-03-31 | -555.53% |
| 2011-12-31 | -523.09% |
| 2011-09-30 | -498.18% |
| 2011-06-30 | -524.39% |
| 2011-03-31 | -399.80% |
| 2010-12-31 | 60.08% |
| 2010-09-30 | -377.37% |
| 2010-06-30 | -322.77% |
| 2010-03-31 | -177.27% |
| 2009-12-31 | -273.46% |
| 2009-09-30 | -178.01% |
| 2009-06-30 | -324.21% |
| 2009-03-31 | -206.45% |
| 2008-12-31 | -249.41% |
| 2008-09-30 | -324.67% |
| 2008-06-30 | -523.07% |
| 2008-03-31 | -15014.23% |
| 2007-12-31 | -305.49% |
| 2007-09-30 | -1508.33% |
| 2007-06-30 | -272.95% |
| 2007-03-31 | -341.09% |
| 2006-12-31 | -1634.19% |
| 2006-09-30 | -1628.49% |
| 2006-06-30 | -1121.77% |
| 2006-03-31 | -80.16% |
| 2005-12-31 | -627.41% |
| 2005-09-30 | -533.42% |
| 2005-06-30 | -742.97% |
| 2005-03-31 | -501.62% |
| 2004-12-31 | -153.63% |
| 2004-09-30 | -700.76% |
| 2004-06-30 | -436.60% |
| 2004-03-31 | -63.00% |
| 2003-12-31 | -467.33% |
| 2003-09-30 | -104.99% |
| 2003-06-30 | -295.19% |
| 2003-03-31 | -493.21% |
| 2002-12-31 | -428.60% |
| 2002-09-30 | -6.06% |
